|
|
Please log in to determine if you are eligible to purchase PT Programs.
|
|
MINIMAL RESIDUAL DISEASE, BCR/ABL1 P190 - MRD1 |
MRD1
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
- Three RNA specimens in sterile water
- For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of BCR::ABL1 fusion transcripts
- Ships on dry ice
Shipping Schedule
-
Shipment A: April 18
-
Shipment B: October 3
|
|
|
|
|
|